Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02744287
Title Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory Winship Cancer Institute Atlanta Georgia 30322 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
University of Chicago Medicine Chicago Illinois 60637 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Nebraska Omaha Nebraska 68198 United States Details
John Theurer Cancer Center, Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Duke University Durham North Carolina 27705 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Baylor Sammons Cancer Center Dallas Texas 75246 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field